Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide and Bimagrumab in Adults With Obesity
NCT05933499Phase 2Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2025
- Primary completion
- Dec 2028
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bimagrumab in obesity, sponsored by Massachusetts General Hospital. Started Nov 2025; status: recruiting.
02
Drugs
bimagrumab
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05933499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05933499.